Marcin Trojanowski, MD

Clinical Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Marcin Trojanowski, MD is Clinical Associate Professor of Medicine Director, Rheumatology Clinic Director, Scleroderma Program Section of Rheumatology Chobanian and Avedisian School of Medicine 72 East Concord Street, 5th floor Boston, MA 02118 Marcin Trojanowski, MD is a Clinical Assistant Professor of Medicine in Rheumatology at Chobanian and Avedisian School of Medicine. He has a decade of experience in treatment of systemic sclerosis as well as a passion for medical teaching.

Prior to his arrival at BUMC, Dr. Trojanowski was the head of the Scleroderma Clinic at UAB where he was the primary referral in the region. In this role he carved out a regional role in both systemic sclerosis as well as CTD-ILD. At BUMC, he has overseen an ever expanding role within the scleroderma clinic. He also serves as the Clinical Director of the Division of Rheumatology. Dr. Trojanowski has worked on many translational and epidemiological research studies such as the Genome Research in African American Scleroderma Patients (GRASP). He has participated in directly sponsored pharmaceutical research as the principle and sub investigator of dozens of drug trials in systemic sclerosis, systemic lupus and more recently COVID 19.

In education, Dr. Trojanowski excelled at UAB as a top ten teacher in the Department of Medicine as well as a leading teacher in the Division of Rheumatology. He was a member of the Strategic Committee on Education at UAB Department of Medicine. At Boston University, Dr. Trojanowski is the director of the rheumatology musculoskeletal module for the second-year medical students and has developed a multidisciplinary problem-based learning module for first year students.

Chief Clinical Interests: Systemic Sclerosis, Connective Tissue Diseases, and Lung Disease in Connective Tissue Disease

Publications

  • Published 2/4/2026

    Lui JK, Cozzolino M, Winburn M, Trojanowski MA, LaValley MP, Bujor AM, Gopal DM, Klings ES. Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain. Rheumatology (Oxford). 2026 Feb 04; 65(2). PMID: 41615697.

    Read at: PubMed

  • Published 2/4/2026

    Kaundal U, Tsou PS, Sahu M, Huang M, Boyden SE, Woodford CM, Shriner D, Stenson E, Safran SA, Zhou Y, Talley TA, Gudapati K, Zhang X, Kunishita Y, Wang J, Shah AA, Mayes MD, Doumatey AP, Bentley AR, Domsic R, Medsger TA, Ramos PS, Silver RM, Steen V, Varga J, Hsu V, Saketkoo LA, Schiopu E, Gordon JK, Criswell LA, Gladue H, Derk C, Bernstein EJ, Bridges SL, Shanmugam V, Chung L, Kafaja S, Jan R, Trojanowski M, Goldberg A, Korman BD, Mullikin J, Thomas JW, Dell'Orso S, Randazzo D, Adeyemo A, Remmers EF, Schwartzberg PL, Aksentijevich I, Rotimi C, Wigley FM, Wang RA, Boin F, Khanna D, Lafyatis R, Kastner DL, Gourh P. Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis. Ann Rheum Dis. 2026 Feb 04. PMID: 41644364.

    Read at: PubMed

  • Published 12/1/2025

    Khanna D, Spino C, Tashkin DP, Bernstein EJ, Goldin J, Kleerup EC, Harui A, Ibrahim G, Kim GHJ, Huang S, McLain R, Tu YH, Nagaraja V, Silver RM, Steen VD, Weigt SS, Lee JS, Fischer A, Scholand MB, Gordon JK, Dellaripa PF, Rosas IO, Hunninghake GM, Trojanowski MA, Simms RW, Dematte JE, Hsu VM, Domsic RT, Raghu G, Mayes MD, Boente RD, Roth MD. Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. ACR Open Rheumatol. 2025 Dec; 7(12):e70126. PMID: 41294296.

    Read at: PubMed

  • Published 7/31/2025

    Lui JK, El-Adili F, Cozzolino M, Winburn M, Trojanowski MA, Gopal DM, LaValley MP, Klings ES, Bujor AM. A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis. PLoS One. 2025; 20(7):e0328734. PMID: 40743121.

    Read at: PubMed

  • Published 7/25/2025

    Dinc MT, El-Adili F, Lui JK, Kripesh S, York M, Trojanowski M, Ligresti G, Lafyatis R, Trojanowska M, Bujor AM. Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways. J Scleroderma Relat Disord. 2025 Jul 25; 23971983251356123. PMID: 40735732.

    Read at: PubMed

View All 23 Publications:   View Full Profile in BUMC

Other Positions

  • Clinic Director, Medicine
    Boston University Chobanian & Avedisian School of Medicine
  • Director, Scleroderma Program, Medicine
    Boston University Chobanian & Avedisian School of Medicine
  • Member, Arthritis & Autoimmune Diseases Research Center
    Boston University

Websites

Education

  • Medical University of South Carolina, MD
  • College of Charleston, BS

View all profiles